dermovate 0.05% ointment
cst pharma ltd - clobetasol propionate - cutaneous ointment - 500microgram/1gram
dermo real- ethyl alcohol gel
saflosa industria real, s.a. de c.v. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.
dermo hubber pomada 5 g
dermotic oil ear drops solution
hill dermaceuticals inc - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - corticosteroids
dermostamin gel
trima israel pharmaceutical products maabarot ltd - dimetindene maleate - gel - dimetindene maleate 0.1 %w/w - dimetindene - urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.
ezetimibe/simvastatin 10 mg/40 mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/20mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/80mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
dermovate cream
taropharma, a division of taro pharmaceuticals inc. - clobetasol propionate - cream - 0.05% - clobetasol propionate 0.05% - anti-inflammatory agents
dermovate ointment
taropharma, a division of taro pharmaceuticals inc. - clobetasol propionate - ointment - .05% - clobetasol propionate .05% - anti-inflammatory agents